JOIN THE BNMS             

               XLargeThumb.00006231-201401000-00000.CV

Twitter @BNMSnews

Molybdenum Supplies

Further problem at NTP - ERT Message

Here is an update on the Mo-99 supply status regarding NTP and OPAL.

19.06.2018 - Read the update from AIPES here

Communicaton below from Jean-Michel Vanderhofstadt, Director General AIPES and Bernard Ponsard, Chairman ERT

Mo---99 Production Activities at NTP Radioisotopes (NTP) 

Brussels, 12 June 2018
The AIPES Emergency Response Team (ERT*) composed of Mo-99 processors, research reactors, and generator manufacturers had a telecon on Tuesday 12 June 2018 to receive an update from NTP Radioisotopes (South Africa) on the temporary interruption of its Mo-99 and I-131 production activities. NTP reported that it had a meeting with the South African National Nuclear Regulator (NNR) on Friday 8 June to identify the information and documentation, which was submitted on Monday 11 June after successful completion. NTP now awaits NNR’s feedback and approval in response to its request to resume Mo-99 production operations.
All actors in the supply chain have instituted back-up plans as well as re-arranged production in order to meet customer requirements to the degree possible and as well to communicate to their customers. AIPES will continue see to the efficient coordination of these mitigation actions and will communicate to the concerned stakeholders as per the ERT processes in place.
Another ERT call will be held on Monday 18 June. 

Temporary Cessation of Mo99 Production activities by NTP Radioisotopes (NTP) - update

UPDATE 13.03.2018 - Read the latest update from AIPES here

Please find a link below to an update provided by AIPES concerning the problem with supply from NTP in South Africa.

View link here

Information on the actual Mo99 supply situation

View the letter below from the Vice President Northern Europe of Mallinckrodt Netherlands Holdings B.V.

Read here

Released 22.11.2017

US National Academies of Sciences Engineering and Medicine report on Molybdenum-99 for Medical Imaging

The US National Academies of Sciences Engineering and Medicine have produced a report on Molybdenum-99 for Medical Imaging. The report can be downloaded by following the the link below:
 
 
The below statement has been released from the OECD HLG-MR Communications sub-group in response to the report.

AIPES press release on Mo99 capacity

An AIPES press release on Mo99 capacity from late 2016 through 2017 has been released.

View press release here

The press release will be posted on the HLG-MR page of the NEA website

Click here for the NEA website

Supply update weeks 11 - 19

There is some risk of supply reduction in March, when ORIS will shut down during weeks 11 and 12 and in April when there are NRU outages in weeks 16, 17, 18.

Other potential risk periods are May, week 19 and June, week 23.

Prof. Alan Perkins, High Level Group on the Security of Supply of Medical Radioisotopes.

Future Supply of Medical Radioisotopes for the UK Report 2014

The BNMS is pleased to publish the report on the 'Future Supply of Medical Radioisotopes for the UK 2014'. In context of the impending closure of two of the world's nuclear reactors involved in the production of Molybdenum, the report assesses the potential impact of this on healthcare services in the UK. The report describes predicted shortages in the Molybdenum supply chain in the period 2016 to 2020, the current status of Nuclear Medicine services in the UK, and explores ways of mitigating the impact of these shortages on patient care pathways. The report additionally explores options for non-reactor production of Technetium-99m in the UK and incorporates details of a visit to the Cyclotron Facilities at Edmonton, Alberta and at TRIUMF, Vancouver BC in Canada by members of the report team.

pdfFuture Supply of Medical Radioisotopes for the UK 2014 Report